1. Home
  2. RVSB vs CNTB Comparison

RVSB vs CNTB Comparison

Compare RVSB & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Riverview Bancorp Inc

RVSB

Riverview Bancorp Inc

N/A

Current Price

$6.11

Market Cap

120.5M

Sector

Finance

ML Signal

N/A

Logo Connect Biopharma Holdings Limited

CNTB

Connect Biopharma Holdings Limited

N/A

Current Price

$0.73

Market Cap

140.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
RVSB
CNTB
Founded
1923
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
120.5M
140.4M
IPO Year
1997
2020

Fundamental Metrics

Financial Performance
Metric
RVSB
CNTB
Price
$6.11
$0.73
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
★ $6.00
AVG Volume (30 Days)
68.8K
★ 949.9K
Earning Date
10-27-2026
11-20-2026
Dividend Yield
★ 1.31%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.08
N/A
Revenue
N/A
★ $64,000.00
Revenue This Year
$42.74
$11,287.85
Revenue Next Year
$5.53
$74.11
P/E Ratio
$76.63
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$4.88
$0.73
52 Week High
$6.22
$3.82

Technical Indicators

Market Signals
Indicator
RVSB
CNTB
Relative Strength Index (RSI) 63.19 35.56
Support Level $5.23 N/A
Resistance Level $6.22 $2.62
Average True Range (ATR) 0.11 0.07
MACD -0.01 0.02
Stochastic Oscillator 70.97 10.67

Price Performance

Historical Comparison
RVSB
CNTB

About RVSB Riverview Bancorp Inc

Riverview Bancorp Inc is the bank holding company. The Company's operations are managed along two operating segments, consisting of banking operations performed by the Bank and trust and investment services performed by the Trust Company. The Bank is engaged mainly in the business of attracting deposits from the general public and using such funds, together with other borrowings, to make various commercial business, commercial real estate, land, multi-family real estate, real estate construction and consumer loans. Additionally, the Trust Company offers trust and investment. Its operations into two operating segments, consisting of banking operations and trust and investment services, these operating segments are aggregated into a single reportable operating segment.

About CNTB Connect Biopharma Holdings Limited

Connect Biopharma Holdings Ltd is a clinical-stage biopharmaceutical company dedicated to transforming care for asthma and chronic obstructive pulmonary disease (COPD). The company is advancing rademikibart, a next-generation antibody designed to target interleukin-4-receptor alpha. It is currently conducting clinical studies of rademikibart for the treatment of acute exacerbations of asthma and COPD. The company operates in one operating segment: treatment of respiratory diseases.

Share on Social Networks: